Tang Siyuan, Huang Lei, Ge Jiahao, Li Jie, Qiu Mingxia, Zhang Yiqing, Long Mei, Wu Gang, Zhang Rui, Ma Xueyun, Xia Qiang, Wan Ping, Yang Taihua
Department of Liver Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, China.
Micro & Nano Inc, Shanghai, 200127, China.
J Nanobiotechnology. 2025 Mar 19;23(1):223. doi: 10.1186/s12951-025-03318-w.
Lipid nanoparticles (LNPs) have revolutionized nucleic acid delivery, enabling significant advances in mRNA-based therapeutics. While extensive research has focused on lipid composition, the impact of preparation solutions on LNP performance remains underexplored. This study systematically investigated the effects of pH, salt type, and concentration across key preparation solutions-mRNA aqueous, dilution, exchange, and storage solutions-on the physicochemical properties, stability, and expression efficiency of SM102-based mRNA/LNPs. Findings revealed that the pH of the mRNA aqueous solution was critical, with a pH of 4 optimizing encapsulation efficiency (EE) and cellular expression. The exchange solution's pH significantly influenced biodistribution, particularly liver-specific expression following intravenous and intramuscular administration. Sucrose was identified as essential for freeze-thaw stability, with a 300 mM concentration minimizing aggregation and mRNA leakage. Furthermore, preparation solutions were shown to influence the structural integrity of LNPs, impacting their in vivo and in vitro performance. These insights highlight the importance of preparation conditions in optimizing LNP formulations for clinical applications, offering a foundation for enhanced therapeutic design and delivery.
脂质纳米颗粒(LNPs)彻底改变了核酸递送方式,推动了基于mRNA的治疗学取得重大进展。尽管大量研究集中在脂质组成上,但制备溶液对LNP性能的影响仍未得到充分探索。本研究系统地研究了pH值、盐类型和浓度对关键制备溶液(mRNA水溶液、稀释液、交换液和储存液)的影响,这些溶液涉及基于SM102的mRNA/LNPs的物理化学性质、稳定性和表达效率。研究结果表明,mRNA水溶液的pH值至关重要,pH值为4时可优化包封效率(EE)和细胞表达。交换液的pH值显著影响生物分布,尤其是静脉内和肌肉内给药后的肝脏特异性表达。已确定蔗糖对冻融稳定性至关重要,300 mM的浓度可最大程度减少聚集和mRNA泄漏。此外,制备溶液被证明会影响LNPs的结构完整性,进而影响其体内和体外性能。这些见解突出了制备条件在优化用于临床应用的LNP制剂中的重要性,为改进治疗设计和递送提供了基础。